A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection versios the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogenic Blood and Marrow Tranplantation (ReSPECT Study)
Date:
01/01/2025
Lead Investigators:
Summary
The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious and safe in the prevention of invasive fungal diseases when compared to the standard antimicrobial regimen.